Stig Lennart Hansson

Founder at CINCLUS PHARMA HOLDING AB

Net worth: 1 M $ as of 2026-05-30

70 year

63 connections

Health Technology

Finance

Commercial Services

Profile

Stig Lennart Hansson is the founder of Sixera Pharma AB, holding the title of Chairman since 2013.
Dr. Hansson is the founder of Cinclus Pharma Holding AB, holding the title of Chairman since 2020.
Dr. Hansson is currently the Chairman of Ignitus AB. Dr. Hansson is currently the Chairman of QureTech Bio AB. Dr. Hansson is currently an Independent Director at Medivir AB since 2018.
Dr. Hansson is currently the Director of HVR Cardio Oy.
Dr. Hansson is currently the Director of InDex Diagnostics AB since 2011.
Dr. Hansson is currently the Director of Beacon Software, Inc. (New York).
Dr. Hansson is currently an Independent Director at InDex Pharmaceuticals AB since 2011.
Former positions include Chief Executive Officer at Arexis AB, Director at CMC Contrast AB, Director at Athera Biotechnologies AB, Independent Non-Executive Director at Calliditas Therapeutics AB, Director at Uminova Invest AB, Director at Nanoxis AB, Director at OxThera AB, Deputy Director at Medtentia AB, Director at Lund University Bioscience AB, Director at Avaris AB, Director at PharmaSurgics In Sweden AB, Deputy Director at Airsonett Holding AB, Director at Malmö Industrifinans AB, Independent Director at Flerie AB, Principal at AstraZeneca AB, Senior Advisor at Industrifonden from 2016 to 2019, Vice President at Biovitrum AB, Investment Manager at Karolinska Development AB (Private Equity), Principal at Kabigen AB, Principal at Karolinska Development AB in 2008, Principal at Symbicom AB, and Member-Supervisory Board at Cinclus Pharma AG.
Education includes a doctorate from Umea Universitet.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CINCLUS PHARMA HOLDING AB 2.33%	2025-12-30	1,084,771 ( 2.33% )	1 M $	2026-05-30

Stig Lennart Hansson active positions

Companies	Position	Start
MEDIVIR AB	Director/Board Member	2018-05-02
CINCLUS PHARMA HOLDING AB	Founder	2013-12-31
Sixera Pharma AB Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome	Founder	2012-12-31
Ignitus AB	Chairman	-
InDex Diagnostics AB InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	2010-12-31
InDex Pharmaceuticals AB InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	2010-12-31
Beacon Software, Inc. /NY/ Beacon Software, Inc. /NY/ Packaged SoftwareTechnology Services Develops software for transportation agencies	Director/Board Member	-
HVR Cardio Oy (Finland) HVR Cardio Oy (Finland) Medical SpecialtiesHealth Technology Develops medical solutions for mitral valve repair	Director/Board Member	2010-08-12
QureTech Bio AB	Chairman	-

All active positions of Stig Lennart Hansson

Former positions of Stig Lennart Hansson

Companies	Position	End
░░░░░░░░░░░░░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Stig Lennart Hansson's experience

Training of Stig Lennart Hansson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stig Lennart Hansson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	32
CMC Contrast AB CMC Contrast AB Pharmaceuticals: MajorHealth Technology develops magnetic resonance contrast agents for patients suffering with tumors	Health Technology
Athera Biotechnologies AB Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs	Health Technology
Medivir AB Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products	Health Technology
AstraZeneca AB AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products	Commercial Services
Industrifonden Industrifonden Investment ManagersFinance Industrifonden invests in companies located in the Nordic region. The firm targets companies operating in the fields of planetary health, life science, deep tech and transformative tech. It provides financing for seed and early stage capital requirements with an investment size of SEK 10 – 50 million.	Finance
Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services	Commercial Services
Karolinska Development AB (Private Equity) Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development seeks investment in companies located in the Nordic region, primarily in Swedish. The firm targets companies operating in the fields of health technology, health services, medical devices, technology services, life science. It provides financing for early stage capital requirements. It takes a seat on the board of directors.	Finance
Flerie AB Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases	Health Technology
Arexis AB Arexis AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
Calliditas Therapeutics AB Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products	Health Technology
Umea Universitet Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Uminova Invest AB Uminova Invest AB Investment ManagersFinance Uminova Invest specializes in seed capital investing. The firm invests exclusively in high-growth projects and businesses with a clear connection to Umeå University or other academic entities and research institutes in the province of Västerbotten, where Umeå is located. Uminova Invest targets science-based projects with unique selling points and significant market potential, in sectors such as biotechnology, IT and medical technology. The firm acquires minority stakes and typically co-invests with their shareholding institutions. In addition to capital they actively contribute business know-how, management support, marketing expertise and access to their network of contacts. They invest primarily in early-stage companies, and may invest during the growth phase as well. Although they aim to exit their investments after three years once their portfolio companies have an established market, Uminova Invest may retain their stake over the longer term. Their preferred exit strategy is through resale, either to the founder or to existing shareholders.	Finance
Nanoxis AB Nanoxis AB Miscellaneous Commercial ServicesCommercial Services Provides tools and services for membrane protein research	Commercial Services
OxThera AB OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure	Health Services
Medtentia AB Medtentia AB Medical SpecialtiesHealth Technology Provides medical devices for cardiac valve surgery	Health Technology
Lund University Bioscience AB Lund University Bioscience AB Investment ManagersFinance LU Bio's investment objective is to create value growth in their innovations for all stakeholders such as the inventors, Lund University, investors and society. Their investment strategy seeks to invest in start-up, early-stage or early-expansion phase projects in the life science field which require capital. They invest across the Nordic region of Sweden, Denmark, Finland and Norway, with a particular focus on Sweden. LU Bio is an active investment partner. They provide both capital and industrial development know-how with the goal of accelerating efficient development of life science innovations. They look to develop high-growth, high-technology and focused portfolio firms. The firm aims to grow defensible and dominant market positions.	Finance
Avaris AB Avaris AB Miscellaneous Commercial ServicesCommercial Services Provides cancer therapies based on gen- and cell-therapy	Commercial Services
PharmaSurgics In Sweden AB PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
Kabigen AB
HVR Cardio Oy (Finland) HVR Cardio Oy (Finland) Medical SpecialtiesHealth Technology Develops medical solutions for mitral valve repair	Health Technology
Karolinska Development AB Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company	Finance
Symbicom AB
InDex Diagnostics AB InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Beacon Software, Inc. /NY/ Beacon Software, Inc. /NY/ Packaged SoftwareTechnology Services Develops software for transportation agencies	Technology Services
Airsonett Holding AB
Sixera Pharma AB Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Conducts research and development of pharmaceuticals treatment for Netherton syndrome	Health Technology
InDex Pharmaceuticals AB InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Ignitus AB
Cinclus Pharma AG Cinclus Pharma AG BiotechnologyHealth Technology Operates as a research based biotech company	Health Technology
Malmö Industrifinans AB Malmö Industrifinans AB Investment Banks/BrokersFinance Engages in buying and selling of shares	Finance
Cinclus Pharma Holding AB Cinclus Pharma Holding AB BiotechnologyHealth Technology Operates as a holding company through its subsidiaries develops small molecules for treatment of gastric acid related diseases	Health Technology
QureTech Bio AB